Item 1.02 Termination of a Material Definitive Agreement.

On June 2, 2020, Cocrystal Pharma, Inc. (the "Company") provided written notice to A.G.P./Alliance Global Partners ("AGP") of its election to terminate the Amended and Restated Equity Distribution Agreement, dated October 30, 2019, by and between the Company and AGP, as amended on January 29, 2020 (the "Agreement"). The termination of the Agreement was effective June 3, 2020.

The material terms of the Agreement are summarized in the Company's Current Reports on Form 8-K filed on October 30, 2019 and January 29, 2020, which are incorporated herein by reference. Such summaries do not purport to be complete and are qualified in their entirety by the full text of the Agreement and amendment thereto, each of which were filed as exhibits to the above-referenced Current Reports on Form 8-K.

© Edgar Online, source Glimpses